Telehealth in Modern Clinical Practice: Opportunities, Barriers, and Future Trajectories

Author

Himasvi M. M., Prathvi M. V., A. R. Shabaraya

Abstract

 Telehealth has transformed healthcare delivery by expanding clinical services across geographical and institutional boundaries using telecommunications and digital infrastructure. Applications span teleconsultation, remote patient monitoring (RPM), telepsychiatry, teledermatology, telepharmacy, digital therapeutics, and virtual multidisciplinary care. While operational before the COVID-19 pandemic, crisis conditions substantially accelerated adoption and demonstrated telehealth’s capacity to maintain care continuity. Evidence confirms that telehealth broadens medical access—particularly for rural and remote populations—reduces travel times, streamlines chronic disease management, and enhances patient convenience. 

However, implementation faces substantial operational barriers, including infrastructure deficits, digital inequity, privacy and cybersecurity vulnerabilities, regulatory uncertainties, clinician burden, and the inability to conduct physical examinations. Because telehealth is not uniformly effective across all clinical conditions, the optimal delivery framework relies on integrated hybrid care models that combine virtual and in-person consultations. In India, the 2020 Telemedicine Practice Guidelines provided a formal regulatory base, though infrastructure, training, and sociocultural barriers persist. Future progress will depend on artificial intelligence, wearable biosensors, interoperable electronic health records, and personalized clinical decision support. Sustainable expansion requires evidence-based regulation, equitable funding, robust security, and targeted strategies to prevent digital exclusion. 

Keywords

Telehealth; Telemedicine; Digital Health; Virtual Care; Remote Patient Monitoring; Teleconsultation; Artificial Intelligence; Healthcare Access; Digital Health Equity.

Full Text:

Download Paper PDF

References

1. World Health Organization. Global strategy on digital health 2020–2025. Geneva: World Health Organization; 2021.
2. Tuckson RV, Edmunds M, Hodgkins ML. Telehealth. N Engl J Med. 2017;377(16):1585-1592. doi:10.1056/NEJMsr1503323.
3. Ekeland AG, Bowes A, Flottorp S. Effectiveness of telemedicine: a systematic review of reviews. Int J Med Inform. 2010;79(11):736-771. doi:10.1016/j.ijmedinf.2010.08.006.
4. Mann DM, Chen J, Chunara R, Testa PA, Nov O. COVID-19 transforms health care through telemedicine: evidence from the field. J Am Med Inform Assoc. 2020;27(7):1132-1135. doi:10.1093/jamia/ocaa072.
5. Hollander JE, Carr BG. Virtually perfect? Telemedicine for Covid-19. N Engl J Med. 2020;382(18):1679-1681. doi:10.1056/NEJMp2003539.
6. Monaghesh E, Hajizadeh A. The role of telehealth during COVID-19 outbreak: a systematic review based on current evidence. BMC Public Health. 2020;20:1193. doi:10.1186/s12889-020-09301-4.
7. World Health Organization. Consolidated telemedicine implementation guide. Geneva: World Health Organization; 2022. ISBN:978-92-4-005918-4.
8. World Health Organization. Global strategy on digital health 2020–2027. Geneva: World Health Organization; 2025. ISBN:978-92-4-011687-0.
9. Kuziemsky C, et al. Telehealth as a means of enabling health equity. Yearb Med Inform. 2022;31(1):183-189.
10. Addressing health service equity through telehealth: a systematic review of reviews. [Systematic review]. 2025.
11. Totten AM, Womack DM, Eden KB, McDonagh MS, Griffin JC, Grusing S, Hersh WR. Telehealth: mapping the evidence for patient outcomes from systematic reviews. Rockville (MD): Agency for Healthcare Research and Quality; 2016. AHRQ Publication No.16-EHC034-EF.
12. Monaghesh E, Hajizadeh A. The role of telehealth during COVID-19 outbreak: a systematic review based on current evidence. BMC Public Health. 2020;20:1193. doi:10.1186/s12889-020-09301-4.
13. Wosik J, Fudim M, Cameron B, et al. Telehealth transformation: COVID-19 and the rise of virtual care. J Am Med Inform Assoc. 2020;27(6):957-962. doi:10.1093/jamia/ocaa067.
14. Cunha AS, Pedro AR, Cordeiro JV. Facilitators of and barriers to accessing hospital medical specialty telemedicine consultations during the COVID-19 pandemic: systematic review. J Med Internet Res. 2023;25:e44188. doi:10.2196/44188.
15. Bitar H, Alismail S. The role of eHealth, telehealth, and telemedicine for chronic disease patients during COVID-19 pandemic: a rapid systematic review. Digit Health. 2021;7:20552076211009396. doi:10.1177/20552076211009396.
16. Flodgren G, Rachas A, Farmer AJ, Inzitari M, Shepperd S. Interactive telemedicine: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2015;(9):CD002098. doi:10.1002/14651858.CD002098.pub2.
17. Kruse CS, Krowski N, Rodriguez B, et al. Telehealth and patient satisfaction: a systematic review and narrative analysis. BMJ Open. 2017;7(8):e016242. doi:10.1136/bmjopen-2017-016242.
18. Chagas MEV, Jacovas VC, Moreira TC, et al. Are we adequately measuring patient satisfaction with telemedicine? A systematic review with a meta-analysis. Telemed J E Health. 2024;30(6):1522-1538. doi:10.1089/tmj.2023.0530.
19. The effectiveness of telepsychiatry: thematic review. BJPsych Bull. 2022. doi:10.1192/bjb.2021.115.
20. Bourkas AN, Barone N, Bourkas MEC, et al. Diagnostic reliability in teledermatology: a systematic review and a meta-analysis. BMJ Open. 2023;13(8):e068207. doi:10.1136/bmjopen-2022-068207.
21. Diagnostic accuracy of teledermatology for skin diseases: a systematic review and meta-analysis. [Systematic review]. 2026. PMID:42663398.
22. Dat TV, Tu VL, Quan NK, et al. Telepharmacy: a systematic review of field application, benefits, limitations, and applicability during the COVID-19 pandemic. Telemed J E Health. 2023;29(2):209-221. doi:10.1089/tmj.2021.0575.
23. Pathak S, Blanchard CM, Moreton E, Urick BY. A systematic review of the effect of telepharmacy services in the community pharmacy setting on care quality and patient safety. J Health Care Poor Underserved. 2021;32(2):737-750. doi:10.1353/hpu.2021.0102.
24. Chong RLK, Chan ASE, Chua CMS, Lai YF. Telehealth interventions in pharmacy practice: systematic review of reviews and recommendations. J Med Internet Res. 2025;27:e57129. doi:10.2196/57129.
25. Houser SH, Flite CA, Foster SL. Privacy and security risk factors related to telehealth services: a systematic review. Perspect Health Inf Manag. 2023;20(1):1b.
26. Watzlaf VJM, Zhou L, Dealmeida DR, Hartman LM. A systematic review of research studies examining telehealth privacy and security practices used by healthcare providers. Int J Telerehabil. 2017;9(2):39-59. doi:10.5195/ijt.2017.6231.
27. Implementation barriers and facilitators of remote monitoring, remote consultation and digital care platforms through the eyes of healthcare professionals: a review of reviews. [Umbrella review]. 2024.
28. Dinakaran D, Manjunatha N, Kumar CN, Math SB. Telemedicine practice guidelines of India, 2020: implications and challenges. Indian J Psychiatry. 2021;63(1):97-101. doi:10.4103/psychiatry.IndianJPsychiatry_476_20.
29. Venkataraman A, Fatma N, Edirippulige S, Ramamohan V. Facilitators and barriers for telemedicine systems in India from multiple stakeholder perspectives and settings: a systematic review. Telemed J E Health. 2024;30(5):1341-1356. doi:10.1089/tmj.2023.0297.
30. Sharma S, et al. Barriers and facilitators for the use of telehealth by healthcare providers in India—a systematic review. [Systematic review]. 2024. PMID:39642108.
31. Dinakaran D, Basavarajappa C, Manjunatha N, Kumar CN, Math SB. Telemedicine practice guidelines and telepsychiatry operational guidelines, India—a commentary. Indian J Psychol Med. 2020;42(5 Suppl):1S-3S. doi:10.1177/0253717620958382.
32. DeNicola N, Grossman D, Marko K, et al. Telehealth interventions to improve obstetric and gynecologic health outcomes: a systematic review. Obstet Gynecol. 2020;135(2):371-382. doi:10.1097/AOG.0000000000003646.
33. De Guzman KR, Gavanescu D, Smith AC, Snoswell C. Economic evaluations of telepharmacy services in non-cancer settings: a systematic review. Res Social Adm Pharm. 2024;20(3):246-254. doi:10.1016/j.sapharm.2024.01.002.
34. Kruse CS, Molina-Nava A, Kapoor Y, Anerobi C, Maddukuri H. Analyzing the effect of telemedicine on domains of quality through facilitators and barriers to adoption: systematic review. J Med Internet Res. 2023;25:e43601. doi:10.2196/43601.
35. Venkatesh U, Aravind GP, Velmurugan AA. Telemedicine practice guidelines in India: global implications in the wake of the COVID-19 pandemic. World Med Health Policy. 2022;14(3):589-599. doi:10.1002/wmh3.497.

Share your valuable work from Social Media Buttons